{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:12:16Z","timestamp":1707523936187},"reference-count":18,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,9,12]]},"DOI":"10.7759\/cureus.45138","type":"journal-article","created":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T00:47:21Z","timestamp":1694566041000},"source":"Crossref","is-referenced-by-count":0,"title":["A Neonate With Cytokine Storm Managed With Steroids, Therapeutic Plasma Exchange, and Tocilizumab"],"prefix":"10.7759","author":[{"given":"Amy","family":"LiKamWa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaitlin","family":"Kobaitri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Balagangadhar R","family":"Totapally","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.siny.2023.101431","article-title":"Multisystem inflammatory disease in neonates (MIS-N) due to maternal COVID-19","volume":"28","author":"Ramaswamy VV","year":"2023","unstructured":"Ramaswamy VV, Abiramalatha T, Pullattayil S AK, Trevisanuto D. Multisystem inflammatory disease in neonates (MIS-N) due to maternal COVID-19. Semin Fetal Neonatal Med. 2023, 28:101431. 10.1016\/j.siny.2023.101431","journal-title":"Semin Fetal Neonatal Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.4049\/immunohorizons.2000104","article-title":"Sepsis, cytokine storms, and immunopathology: the divide between neonates and adults","volume":"5","author":"Greenfield KG","year":"2021","unstructured":"Greenfield KG, Badovinac VP, Griffith TS, Knoop KA. Sepsis, cytokine storms, and immunopathology: the divide between neonates and adults. Immunohorizons. 2021, 5:512-22. 10.4049\/immunohorizons.2000104","journal-title":"Immunohorizons"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra2026131","article-title":"Cytokine storm","volume":"383","author":"Fajgenbaum DC","year":"2020","unstructured":"Fajgenbaum DC, June CH. Cytokine storm. N Engl J Med. 2020, 383:2255-73. 10.1056\/NEJMra2026131","journal-title":"N Engl J Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0000000000003559","article-title":"Therapeutic plasma exchange in children with thrombocytopenia-associated multiple organ failure: the thrombocytopenia-associated multiple organ failure network prospective experience","volume":"47","author":"Fortenberry JD","year":"2019","unstructured":"Fortenberry JD, Nguyen T, Grunwell JR, et al.. Therapeutic plasma exchange in children with thrombocytopenia-associated multiple organ failure: the thrombocytopenia-associated multiple organ failure network prospective experience. Crit Care Med. 2019, 47:e173-81. 10.1097\/CCM.0000000000003559","journal-title":"Crit Care Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2022.106511","article-title":"Glucocorticoids and COVID-19","volume":"185","author":"Bruscoli S","year":"2022","unstructured":"Bruscoli S, Puzzovio PG, Zaimi M, Tiligada K, Levi-Schaffer F, Riccardi C. Glucocorticoids and COVID-19. Pharmacol Res. 2022, 185:106511. 10.1016\/j.phrs.2022.106511","journal-title":"Pharmacol Res"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1038\/nri.2017.1","article-title":"Immune regulation by glucocorticoids","volume":"17","author":"Cain DW","year":"2017","unstructured":"Cain DW, Cidlowski JA. Immune regulation by glucocorticoids. Nat Rev Immunol. 2017, 17:233-47. 10.1038\/nri.2017.1","journal-title":"Nat Rev Immunol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2023.8516","article-title":"Dexamethasone for inpatients with COVID-19 in a national cohort","volume":"6","author":"Mourad A","year":"2023","unstructured":"Mourad A, Thibault D, Holland TL, Yang S, Young AR, Arnold Egloff SA, Thomas LE. Dexamethasone for inpatients with COVID-19 in a national cohort. JAMA Netw Open. 2023, 6:e238516. 10.1001\/jamanetworkopen.2023.8516","journal-title":"JAMA Netw Open"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.21039","article-title":"HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis","volume":"48","author":"Henter JI","year":"2007","unstructured":"Henter JI, Horne A, Aric\u00f3 M, et al.. HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer. 2007, 48:124-31. 10.1002\/pbc.21039","journal-title":"Pediatr Blood Cancer"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1002\/jca.21470","article-title":"Guidelines on the use of therapeutic apheresis in clinical practice-evidence-based approach from the writing committee of the American Society for Apheresis: the seventh special issue","volume":"31","author":"Schwartz J","year":"2016","unstructured":"Schwartz J, Padmanabhan A, Aqui N, et al.. Guidelines on the use of therapeutic apheresis in clinical practice-evidence-based approach from the writing committee of the American Society for Apheresis: the seventh special issue. J Clin Apher. 2016, 31:149-62. 10.1002\/jca.21470","journal-title":"J Clin Apher"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/s0749-0704(01)00010-0","article-title":"Plasmapheresis. Technical aspects and indications","volume":"18","author":"Madore F","year":"2002","unstructured":"Madore F. Plasmapheresis. Technical aspects and indications. Crit Care Clin. 2002, 18:375-92. 10.1016\/s0749-0704(01)00010-0","journal-title":"Crit Care Clin"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1159\/000351283","article-title":"Plasmapheresis as an alternative to high-dose intravenous immunoglobulin in the prevention of gestational alloimmune liver disease","volume":"34","author":"Hutchings G","year":"2013","unstructured":"Hutchings G, Williams O, Sokal E, Wittington PF. Plasmapheresis as an alternative to high-dose intravenous immunoglobulin in the prevention of gestational alloimmune liver disease. Fetal Diagn Ther. 2013, 34:180-3. 10.1159\/000351283","journal-title":"Fetal Diagn Ther"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.transci.2018.01.011","article-title":"Solutions to technical challenges during therapeutic plasma exchange using the Spectra Optia on a 4\u202fkilogram neonate","volume":"57","author":"Mathur G","year":"2018","unstructured":"Mathur G, Collins L, Tigges CR, Schlueter AJ. Solutions to technical challenges during therapeutic plasma exchange using the Spectra Optia on a 4\u202fkilogram neonate. Transfus Apher Sci. 2018, 57:201-3. 10.1016\/j.transci.2018.01.011","journal-title":"Transfus Apher Sci"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2017.1316909","article-title":"Tocilizumab (Actemra)","volume":"13","author":"Sheppard M","year":"2017","unstructured":"Sheppard M, Laskou F, Stapleton PP, Hadavi S, Dasgupta B. Tocilizumab (Actemra). Hum Vaccin Immunother. 2017, 13:1972-88. 10.1080\/21645515.2017.1316909","journal-title":"Hum Vaccin Immunother"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2020.105954","article-title":"Cytokine release syndrome in severe COVID-19: interleukin-6 receptor antagonist tocilizumab may be the key to reduce mortality","volume":"55","author":"Zhang C","year":"2020","unstructured":"Zhang C, Wu Z, Li JW, Zhao H, Wang GQ. Cytokine release syndrome in severe COVID-19: interleukin-6 receptor antagonist tocilizumab may be the key to reduce mortality. Int J Antimicrob Agents. 2020, 55:105954. 10.1016\/j.ijantimicag.2020.105954","journal-title":"Int J Antimicrob Agents"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2028700","article-title":"Tocilizumab in hospitalized patients with severe Covid-19 pneumonia","volume":"384","author":"Rosas IO","year":"2021","unstructured":"Rosas IO, Br\u00e4u N, Waters M, et al.. Tocilizumab in hospitalized patients with severe Covid-19 pneumonia. N Engl J Med. 2021, 384:1503-16. 10.1056\/NEJMoa2028700","journal-title":"N Engl J Med"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.39604","article-title":"Prevalence of hospital-acquired pneumonia among patients with severe to critical COVID-19 pneumonia given tocilizumab","volume":"15","author":"Adre LA","year":"2023","unstructured":"Adre LA, Catangui JS 3rd, Bondoc MK, Abdurahman KM. Prevalence of hospital-acquired pneumonia among patients with severe to critical COVID-19 pneumonia given tocilizumab. Cureus. 2023, 15:e39604. 10.7759\/cureus.39604","journal-title":"Cureus"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1159\/000524202","article-title":"Multisystemic inflammatory syndrome in neonates: a systematic review","volume":"119","author":"Shaiba LA","year":"2022","unstructured":"Shaiba LA, More K, Hadid A, Almaghrabi R, Al Marri M, Alnamnakani M, Shah P. Multisystemic inflammatory syndrome in neonates: a systematic review. Neonatology. 2022, 119:405-17. 10.1159\/000524202","journal-title":"Neonatology"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-016-1570-4","article-title":"The inflammatory response to extracorporeal membrane oxygenation (ECMO): a review of the pathophysiology","volume":"20","author":"Millar JE","year":"2016","unstructured":"Millar JE, Fanning JP, McDonald CI, McAuley DF, Fraser JF. The inflammatory response to extracorporeal membrane oxygenation (ECMO): a review of the pathophysiology. Crit Care. 2016, 20:387. 10.1186\/s13054-016-1570-4","journal-title":"Crit Care"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/183906-a-neonate-with-cytokine-storm-managed-with-steroids-therapeutic-plasma-exchange-and-tocilizumab","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:53:11Z","timestamp":1707508391000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/183906-a-neonate-with-cytokine-storm-managed-with-steroids-therapeutic-plasma-exchange-and-tocilizumab"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,12]]},"references-count":18,"URL":"https:\/\/doi.org\/10.7759\/cureus.45138","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9,12]]}}}